Equities

Cronos Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Cronos Group Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)3.52
  • Today's Change-0.04 / -1.12%
  • Shares traded146.33k
  • 1 Year change+24.82%
  • Beta1.1963
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

  • Revenue in CAD (TTM)179.66m
  • Net income in CAD49.00m
  • Incorporated2020
  • Employees626.00
  • Location
    Cronos Group Inc4491 Concession Rd 12TORONTO L0M 1S0CanadaCAN
  • Phone+1 (416) 504-0004
  • Fax+1 (416) 504-0004
  • Websitehttps://thecronosgroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CRON:TOR since
announced
Transaction
value
CanAdelaar BVAnnounced09 Dec 202509 Dec 2025Announced2.33%66.91m
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cipher Pharmaceuticals Inc67.94m23.57m359.50m61.0015.982.3310.905.290.88990.88992.566.100.33222.154.291,113,847.0011.5219.6313.0323.1774.3279.7434.6959.540.97665.740.10520.0057.668.24-43.3634.34127.59--
Spectral Medical Inc2.71m-41.69m380.33m29.00------140.60-0.1455-0.14560.0095-0.23750.3314.437.0393,275.86-510.19-135.57---711.8956.1655.19-1,541.33-581.020.1044-0.1904----43.05-4.430.7223---30.03--
Knight Therapeutics Inc413.85m-3.49m582.52m745.00--0.76711.211.41-0.0378-0.03784.127.690.41161.843.96555,498.00-0.34740.0976-0.40150.114342.4946.11-0.8440.3511.68--0.12170.0013.1350.90125.73-21.4860.58--
Canopy Growth Corp278.39m-327.29m585.86m960.00--0.7043--2.10-1.85-1.841.162.060.24522.087.59289,988.50-28.83-30.76-31.54-33.9526.568.54-117.57-315.364.26-0.17610.2518---9.47-7.57-24.90---56.47--
DRI Healthcare Trust192.69m-52.24m872.37m36.00--2.0017.534.53-0.9453-0.94533.457.930.2149--3.915,352,556.00-5.83---6.38-------27.11----1.820.5077--16.24---103.68------
Cronos Group Inc179.66m49.00m1.35bn626.0028.980.927719.277.530.12290.12290.46263.840.1121.575.56--3.51-8.993.81-9.7743.352.2231.36-159.1521.28--0.00--34.8237.71158.81-48.79-19.52--
Bausch Health Companies Inc13.61bn491.38m3.06bn20.70k6.28--1.460.2251.311.3136.62-2.070.37591.814.45657,650.401.20-1.661.52-2.0670.6771.263.20-5.560.97041.320.9834--9.912.2892.23--4.11--
Data as of Feb 12 2026. Currency figures normalised to Cronos Group Inc's reporting currency: Canadian Dollar CAD

Institutional shareholders

8.05%Per cent of shares held by top holders
HolderShares% Held
Chescapmanager LLCas of 30 Sep 20257.95m2.08%
Tidal Investments LLCas of 30 Sep 20254.96m1.30%
D. E. Shaw & Co. LPas of 30 Sep 20253.87m1.01%
Dimensional Fund Advisors LPas of 08 Jan 20263.53m0.92%
Cannell Capital LLCas of 30 Sep 20251.96m0.51%
RBC Dominion Securities, Inc. (Investment Management)as of 30 Sep 20251.94m0.51%
Renaissance Technologies LLCas of 30 Sep 20251.77m0.46%
MM Asset Management, Inc.as of 30 Sep 20251.77m0.46%
Citadel Securities LLCas of 30 Sep 20251.61m0.42%
Quinn Opportunity Partners LLCas of 30 Sep 20251.47m0.39%
More ▼
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.